149 related articles for article (PubMed ID: 34648681)
41. Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
Cox CV; Diamanti P; Moppett JP; Blair A
PLoS One; 2016; 11(10):e0165210. PubMed ID: 27764235
[TBL] [Abstract][Full Text] [Related]
42. [Characteristics and monitoring of minimal residual disease in patients with T acute lymphoid leukemia by flow cytometry with two 4-color combinations of fluorescent antibodies].
Li L; Yuan XJ; Xu C; Jiang LM; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1103-9. PubMed ID: 23114128
[TBL] [Abstract][Full Text] [Related]
43. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
Gore SD; Kastan MB; Goodman SN; Civin CI
J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
[TBL] [Abstract][Full Text] [Related]
44. Flow cytometric characterization of acute leukemia reveals a distinctive "blast gate" of murine T-lymphoblastic leukemia/lymphoma.
Pan Z; Yang M; Huang K; Büsche G; Glage S; Ganser A; Li Z
Oncotarget; 2018 Jan; 9(2):2320-2328. PubMed ID: 29416774
[TBL] [Abstract][Full Text] [Related]
45. High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
Del Principe MI; Buccisano F; Cefalo M; Maurillo L; Di Caprio L; Di Piazza F; Sarlo C; De Angelis G; Irno Consalvo M; Fraboni D; De Santis G; Ditto C; Postorino M; Sconocchia G; Del Poeta G; Amadori S; Venditti A
Ann Hematol; 2014 Sep; 93(9):1509-13. PubMed ID: 24752416
[TBL] [Abstract][Full Text] [Related]
46. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
[TBL] [Abstract][Full Text] [Related]
47. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
48. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
[TBL] [Abstract][Full Text] [Related]
49. Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry.
Arumugam JR; Bommannan K; Radhakrishnan V; Sagar TG; Sundersingh S
Leuk Lymphoma; 2022 Mar; 63(3):644-652. PubMed ID: 34727819
[TBL] [Abstract][Full Text] [Related]
50. Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies.
Imamura N; Kuramoto A
Am J Hematol; 1991 Dec; 38(4):332-4. PubMed ID: 1836104
[TBL] [Abstract][Full Text] [Related]
51. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M
Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867
[TBL] [Abstract][Full Text] [Related]
52. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
53. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
54. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome.
Alves GV; Fernandes AL; Freire JM; Paiva Ade S; Vasconcelos RC; Sales VS; Lemos TM; Gil EA; Freire FH; Cavalcanti e Silva DG; Maciel JF; Farkatt IG; Cavalcanti Júnior GB
J Clin Lab Anal; 2012 Nov; 26(6):431-40. PubMed ID: 23143625
[TBL] [Abstract][Full Text] [Related]
55. [CD45 gating of acute leukemia].
Nishikawa K; Miyasaki T; Tsukaguchi N; Noma Y; Nakagawa K; Narita N
Rinsho Byori; 1996 Jun; 44(6):548-53. PubMed ID: 8752733
[TBL] [Abstract][Full Text] [Related]
56. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
57. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
Hanson CA; Ross CW; Schnitzer B
Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
[TBL] [Abstract][Full Text] [Related]
58. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome.
Ito S; Ishida Y; Murai K; Kuriya S
Leuk Res; 2001 Mar; 25(3):205-11. PubMed ID: 11226515
[TBL] [Abstract][Full Text] [Related]
60. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
